Although the existence of Cα−H···OC hydrogen bonds in protein structures recently has been
established, little is known about their strength and, therefore, the relative importance of these interactions.
We have discovered that similar interactions occur in N,N-dimethylformamide dimers. High level ab initio
calculations (MP2/aug-cc-pTZV) yield electronic association energies (D
e) and association enthalpies (ΔH
298)
for four dimer geometries. These data provide a lower limit of D
e = −2.1 kcal mol-1 for the Cα−H···OC
hydrogen bond. A linear correlation between C−H···O bond energies and gas-phase proton affinities is reported.
The gas-phase anion proton affinity of a peptide Cα−H hydrogen was calculated (355 kcal mol-1) and used
to estimate values of D
e = −4.0 ± 0.5 kcal mol-1 and ΔH
298 = −3.0 ± 0.5 kcal mol-1 for the Cα−H···OC
hydrogen bond. The magnitude of this interaction, roughly one-half the strength of the N−H···OC hydrogen
bond, suggests that Cα−H···OC hydrogen bonding interactions represent a hitherto unrecognized, significant
contribution in the determination of protein conformation.
This article summarizes experimental and theoretical evidence for the existence of four distinct binding modes for complexes of anions with charge-neutral arenes. These include C-H hydrogen bonding and three motifs involving the arene-pi system-the noncovalent anion-pi interaction, weakly covalent sigma interaction, and strongly covalent sigma interaction.
This paper refines the nature of the interactions between electron-deficient arenes and halide
anions. Conclusions are based on (i) new crystal structures containing alkali halide salts with 1,2,4,5-tetracyanobenzene (TCB) and 18-crown-6, (ii) evaluation of crystal structures found in the Cambridge
Structural Database, and (iii) MP2/aug-cc-pVDZ calculations of F-, Cl-, and Br- complexes with TCB,
1,3,5-tricyanobenzene, triazine, and hexafluorobenzene. When the halide lies above the plane of the π
system, the results establish that three distinctly different types of complexes are possible: strongly covalent
σ complexes, weakly covalent donor−π-acceptor complexes, and noncovalent anion−π complexes. When
aryl C−H groups are present, a fourth type of interaction leads to C−H · · · X- hydrogen bonding.
Characterization of the different geometries encountered with the four possible binding motifs provides
criteria needed to design host architectures containing electron-deficient arenes.
The structures of the dimers of formamide and N-methylacetamide have been calculated at the ab initio electronic structure theory level, second-order Møller-Plesset perturbation theory (MP2) with augmented correlation consistent basis sets. Five unique structures were optimized for the formamide dimers at the MP2/ aug-cc-pVDZ and MP2/aug-cc-pVTZ levels. At the optimized geometries obtained with the aug-cc-pVTZ basis set, MP2 energies were evaluated with the aug-cc-pVQZ basis set, allowing an extrapolation of the energies to the complete basis set limit. Four structures were found for the N-methylacetamide dimer at the MP2/aug-cc-pVDZ level, and single-point energies were calculated at the MP2/aug-cc-pVTZ level. In both systems, the basis set superposition error was estimated with the counterpoise method. The strength of the NsH‚‚‚OdC bond has a mean value of 7.1 kcal/mol in the formamide dimers and a mean value of 8.6 kcal/mol in the N-methylacetamide dimers. The difference in hydrogen bond strengths is attributed to differences in basicity at the carbonyl oxygen receptor site. In several dimers CsH‚‚‚OdC hydrogen bonds play an important role in stabilizing these intermolecular complexes, increasing the interaction energy by 1.1-2.6 kcal/mol per interaction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.